Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy

Luca Degli Esposti1 Clicon S.r.l. Health, Economics & Outcomes Research, Ravenna, ItalyCorrespondence[email protected]

Chiara Veronesi1 Clicon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy

Valentina Perrone1 Clicon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy

Stefano Buda1 Clicon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy

Antonio Santoro2 Department of Nephrology and Dialysis, Policlinico S. Orsola-Malpighi, Bologna, Italy

Pages 233-239 | Published online: 27 Apr 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ChapmanABDevuystOEckardtKUAutosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies ConferenceKidney Int2015881172725786098
PubMed Web of Science ®Google Scholar
TorresVEHarrisPCPirsonYAutosomal dominant polycystic kidney diseaseLancet200736995691287130117434405
PubMed Web of Science ®Google Scholar
WilleyCJBlaisJDHallAKKrasaHBMakinAJCzerwiecFSPrevalence of autosomal dominant polycystic kidney disease in the European UnionNephrol Dial Transplant Epub2016619
PubMed Web of Science ®Google Scholar
BlanchetteCMMatterSChawlaAJGutierrezBBurden of autosomal dominant polycystic kidney disease: Systematic literature reviewAm J Pharm Benefits201572e27e36
Google Scholar
TakiarVCaplanMJPolycystic kidney disease: pathogenesis and potential therapiesBiochim Biophys Acta20111812101337134321146605
PubMed Web of Science ®Google Scholar
AlamAPerroneRDManagement of ESRD in patients with autosomal dominant polycystic kidney diseaseAdv Chronic Kidney Dis20101716417220219619
PubMed Web of Science ®Google Scholar
IgarashiPSomloSGenetics and pathogenesis of polycystic kidney diseaseJ Am Soc Nephrol20021392384239812191984
PubMed Web of Science ®Google Scholar
GranthamJJAutosomal dominant polycystic kidney diseaseN Engl J Med20083591477148518832246
PubMed Web of Science ®Google Scholar
SpithovenEMKramerAMeijerERenal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival–an analysis of data from the ERA-EDTA RegistryNephrol Dial Transplant201429Suppl 4iv15iv2525165182
PubMed Web of Science ®Google Scholar
OngACDevuystOKnebelmannBWalzGERA-EDTA Working Group for Inherited Kidney DiseasesAutosomal dominant polycystic kidney disease: the changing face of clinical managementLancet201538599811993200226090645
PubMed Web of Science ®Google Scholar
KühnWEWalzGThe treatment of autosomal dominant polycystic kidney diseaseDtsch Ärztebl Int201511251–5288489026900155
PubMed Web of Science ®Google Scholar
PerroneVSangiorgiDBudaSDegli EspostiLDisease progression and health care resource consumption in patients affected by hepatitis C virus in real practice settingClinoecon Outcomes Res20168591597
PubMed Web of Science ®Google Scholar
AIFA Guideline for the classification and conduction of the observational studies on medicines Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdfAccessed February 20, 2017
Google Scholar
Opinion 05/2014 on Privacy and Data Protection Available from: http://ec.europa.eu/justice/data-protection/article-29/documentation/opinion-recommendation/files/2014/wp216_it.pdfAccessed February 20, 2017
Google Scholar
WoonCBielinski-BradburyAO’ReillyKRobinsonPA systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney diseaseBMC Nephrol20151614026275819
PubMed Web of Science ®Google Scholar
McEwanPBennettHO’ReillyKRobinsonPQuantifying the impact of treatment on the public health burden of adpkd: a Uk case study using the adpkd outcomes modelValue Health187A763
Web of Science ®Google Scholar
BlanchetteCMCraverCBelkKWLubeckDPRossettiSGutierrezBHospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the USJ Med Econ201518430331125372357
PubMed Web of Science ®Google Scholar
KnightTGSchaeferCKrasaHOberdhanDChapmanAPerroneREconomic burden of autosomal dominant polycystic kidney disease in the United States (Abstract 160)Am J Kidney Dis2013614A55
Web of Science ®Google Scholar
ErikssonDKarlssonLEklundOAutosomal polycystic kidney disease (Adpkd): costs and resource utilisation in the Nordic CountriesValue Health2015187A513
Web of Science ®Google Scholar
European ADPKD Forum, gennaio2015Tradurre le conoscenze in strategie politiche per migliorare la cura della malattia policistica renale autosomica dominante in Europa Available from: http://www.pkdinternational.org/eaf_adpkd_forum_policy_report_2015/Accessed May 13, 2016
Google Scholar
KnightTSchaeferCKrasaHOberdhanDChapmanAPerroneRDMedical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataClincoecon Outcomes Res20157123132
PubMed Web of Science ®Google Scholar
HoneycuttAASegelJEZhuoXHoergerTJImaiKWilliamsDMedical costs of CKD in the medicare populationJ Am Soc Nephrol20132491478148323907508
PubMed Web of Science ®Google Scholar
LentineKLXiaoHMachnickiGGheorghianASchnitzlerMARenal function and healthcare costs in patients with polycystic kidney diseaseClin J Am Soc Nephrol201051471147920538839
PubMed Web of Science ®Google Scholar
Ministero della SaluteDocumento di indirizzo per la malattia renale cronica112014 Available from: http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&id=2244Accessed February 20, 2017
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date